# Part 1: Dose-Finding of HSK3486 Injection In Nondependent, Recreational Central Nervous System Depressant Users

> **NCT07404306** · PHASE1 · COMPLETED · sponsor: **Haisco-USA Pharmaceuticals, Inc.** · enrollment: 43 (actual)

## Conditions studied

- General Anesthesia

## Interventions

- **DRUG:** HSK3486
- **DRUG:** propofol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07404306
- **Lead sponsor:** Haisco-USA Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-16
- **Primary completion:** 2023-10-03
- **Final completion:** 2023-10-03
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2026-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07404306

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07404306, "Part 1: Dose-Finding of HSK3486 Injection In Nondependent, Recreational Central Nervous System Depressant Users". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07404306. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*